Georgia Tech is developing processes and techniques for ensuring a consistent, low-cost, large-scale manufacture of high-quality living cells used in cell-based therapies. The therapies will be used for a variety of disorders such as cancer, lung fibrosis, autism, neuro-degenerative diseases, autoimmune disorders, and spinal-cord injury – as well as in regenerative medicine.
The Marcus Center for Therapeutic Cell Characterization and Manufacturing was established in 2016 bringing together bioengineers, manufacturing engineers, and industrial engineers to work closely with cell biologists, clinicans, and industry partners.
